All legislation must also be passed by the Senate before it can be sent to President Joe Biden to be signed into law. It is unclear how many of the measures will make it that far given the limited number of days the Senate is in session for the rest of the year. But their success in the House could pave the way for even stronger regulatory moves in the next Congress, Singleton said. The Chinese companies, whose work includes cancer research and manufacturing for American drugmakers, say data privacy is not at risk and that the measure will limit competition. “We are disappointed that the U.S. legislative process is being used to pick winners and losers,” Shenzhen-based BGI Group said in a statement.

---

Persons: Joe Biden, Singleton, “ Organizations: Senate, Biotech, ”, WuXi AppTec, Hong Kong Lawmakers, Authorities, Hong, Foreign Ministry, U.S Locations: Beijing, ” Shenzhen, WuXi, Washington , New York, San Francisco, China, British, Hong Kong